Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS

Clinical trial NCT00168766 · COMPLETED

Trial details

NCT number: NCT00168766
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Relapsing-remitting Multiple Sclerosis

Start date: 2003-01-01
Primary completion: 2008-11-01
Enrollment: 345

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.